Compared with Alzheimer’s disease, elevated tau or reduced amyloid-β1–42 are usually not found in other forms of neurodegenerative dementia (e.g. tauopathies, vascular dementia, Lewy body disease) (Grossman et al., 2005; Hu et al., 2010). This evidence concerns the gene MAPT and vascular dementia.